Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events
Hideki Iwamoto, Takuji Torimura(Omuta hospital), Masahito Nakano(Kurume University), Hironori Koga(Kurume University), Naoki Kamachi(Kurume University), Atsutaka Masuda(Kurume University), Dan Nakano(Kurume University), Miwa Sakai(Kurume University), Shigeo Shimose(Kurume University), Tõru Nakamura, Ryoko Kuromatsu(Kurume University), Takashi Niizeki(Kurume University), Toshimitsu Tanaka(Kurume University), Hiroyuki Suzuki(Kurume University), Taizo Yamaguchi, Takahiko Sakaue(Kurume University), Yu Noda(Kurume University), Shusuke Okamura(Kurume University), Tomotake Shirono(Kurume University)
Cited by 68
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410